Don’t miss the latest developments in business and finance.

Sun Pharma surpasses SBI in m-cap ranking

Sun Pharma with a m-cap of Rs 2,16,637 crore was ahead of the SBI which having m-cap of Rs 2,11,467 crore.

SI Reporter Mumbai
Last Updated : Mar 17 2015 | 11:34 AM IST
Sun Pharmaceuticals Industries, the pharmaceutical giant has surpasses the State Bank of India (SBI), the country’s largest public-sector lender in overall market capitalization (m-cap) ranking.

At 1116 hours, Sun Pharma with a m-cap of Rs 2,16,637 crore was ahead of the SBI which having m-cap of Rs 2,11,467 crore, the BSE data shows.

Market capitalisation or the value of a listed company is arrived at by multiplying the total number of its shares with its stock price on a particular day or time.

Shares of Sun Pharma have outperformed the market by surging 27% so far in 2015, compared to 9% declined in the market value of SBI. The benchmark S&P BSE Sensex was gained 4.6% during the same period.

Currently, Sun Pharma stands at number eight position in overall m-cap ranking, ahead of the housing finance major Housing Development Finance Corporation (HDFC) and the fast moving consumer goods company Hindustan Unilever.

Coal India with Rs 2,31,242 crore m-cap is at number seven position in m-cap ranking.

Tata Consultancy Services (TCS) is on top of the list with m-cap of Rs 5,08,554 crore followed by Reliance Industries, ITC, Oil and Natural Gas Corporation, HDFC Bank and Infosys having m-cap of between Rs 2,60,000 to Rs 2,76,000 crore.
 

Also Read

First Published: Mar 17 2015 | 11:31 AM IST

Next Story